Cancer metabolism as a therapeutic target: metabolic synthetic lethality
Oncology (Williston Park)
.
2013 May;27(5):467, 473-4.
Authors
Karim Bensaad
1
,
Adrian L Harris
Affiliation
1
CRUK Growth Factor Group, The Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom; and John Radcliffe Hospital, Headington, Oxford.
PMID:
25184271
No abstract available
Publication types
Comment
MeSH terms
Glycolysis / drug effects*
Humans
Neoplasms / drug therapy*
Neoplasms / metabolism*